InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the complete record of transactions filed by Dreyfus Andrew, 董事. Insider active across 1 company, notably Ironwood Pharmaceuticals INC. Aggregated, 8 reports have been published. History available since 2 June 2021. The latest transaction was disclosed on 10 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Dreyfus Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
45,000 股0Class A Common StockSEC:0000950170-25-085437:0
24,311 股0Class A Common StockSEC:0000950170-24-076211:0
22,350 股0Class A Common StockSEC:0001209191-23-039134:0
21,571 股0Class A Common StockSEC:0001209191-22-033965:0
1,431 股0Class A Common StockSEC:0001209191-21-070234:0
1,344 股0Class A Common StockSEC:0001209191-21-056656:0
1,453 股0Class A Common StockSEC:0001209191-21-040921:0
22,766 股0Class A Common StockSEC:0001209191-21-038191:0
8 条申报中的 8 条
About Dreyfus Andrew
Andrew Dreyfus is a Board Member at Ironwood Pharmaceuticals Inc. He brings valuable expertise to the board, contributing to the company's strategy and governance. His experience in the pharmaceutical sector allows him to provide unique insights into market challenges and growth opportunities. His role is essential in guiding Ironwood towards a prosperous future.
